Using Visual Displays in a Manualized Cognitive-Behavioral Treatment for Adults With ADHD and Comorbid Mood or Anxiety Disorders: A Pilot Study

Attention-deficit/hyperactivity disorder (ADHD) in adults is a major health concern, often occurring with other disorders and functional, occupational, and relational deficits. Unfortunately, many treatment studies for adults with ADHD exclude comorbid mood or anxiety disorders. The present two-part...

Full description

Saved in:
Bibliographic Details
Published inCognitive and behavioral practice
Main Authors Pagán, Antonio F., Mumma, Gregory H., Littlefield, Andrew K.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2023
Subjects
anxiety disorders
attention-deficit/hyperactivity disorder
cognitive behavioral case formulation
cognitive behavioral therapy
comorbidity
idiographic assessment
mood disorders
network analysis
single subjects design
cognitive behavioral therapy
idiographic assessment
comorbidity
mood disorders
cognitive behavioral case formulation
attention-deficit/hyperactivity disorder
anxiety disorders
network analysis
single subjects design
Online AccessGet full text

Cover

More Information
Summary:Attention-deficit/hyperactivity disorder (ADHD) in adults is a major health concern, often occurring with other disorders and functional, occupational, and relational deficits. Unfortunately, many treatment studies for adults with ADHD exclude comorbid mood or anxiety disorders. The present two-part study sought to identify the feasibility, acceptability, and preliminary effectiveness of a treatment for adults with ADHD and comorbid mood or anxiety disorders that used modules from evidence-based cognitive-behavioral (CB) and mindfulness interventions for adult ADHD and mood or anxiety disorders. Selection of modules for each participant’s treatment was guided by participant input (e.g., top problems) and personalized visual displays. Visual displays included a CB case formulation and intraindividual network analyses, using pretreatment ecological momentary assessment (EMA) data completed two or three times a day to assess ADHD and comorbid symptoms. All 9 (6 women) participants completed the pretreatment standardized measures—however, completion of EMA data by 6 participants provides mixed support for the feasibility of utilizing EMA with ADHD adults. Nevertheless, the results indicate feasibility for using this CB treatment combining manualized interventions with treatment personalization using complex visual displays from available EMA data. Seven of 9 (77.8%) participants achieved a reliable change and 5 (55.6%) achieved a clinically significant change in total ADHD symptoms (Barkley Adult ADHD-IV Rating Scale) at posttreatment and/or 3-month follow-up. Inattention symptoms reliably decreased in all participants.
ISSN:1077-7229
1878-187X
DOI:10.1016/j.cbpra.2023.08.003